Skip to content

Clinical trials

Phase 1/2 Heart Failure trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 1/2 Country / region: United States Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20033
20051
20063
20073
20093
20103
20114
20123
20133
20142
20153
20173
20184
20191
20203
20213
20222
20232
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Terminated6
Withdrawn5
Unknown status4
Active, not recruiting3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic4
University of Pennsylvania4
US Department of Veterans Affairs3
Virginia Commonwealth University3
Capricor Inc.2
Celladon Corporation2
Horng Chen2
Washington University School of Medicine2
Abbott Medical Devices1
Abramson Cancer Center at Penn Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure53
Cardiomyopathy, Dilated4
Cardiomyopathies3
Cardiovascular Diseases3
Inflammation3
Euthyroid Sick Syndromes2
Heart Diseases2
Myocardial Infarction2
Pulmonary Disease, Chronic Obstructive2
Adenoviridae Infections1

Trials

Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.